Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22335650 | 0.80 | ALDH1A1 (0.52) | ALDH1A1SLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL7832703 | 0.80 | KMT2A (0.37) | ALDH1A1SLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL2767887 | 0.76 | ALDH1A1 (0.45) | ALDH1A1SLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL16063070 | 0.76 | ALDH1A1 (0.51) | ALDH1A1SLC6A3TDP1HPGDLMNA | |
| SCHEMBL4621793 | 0.74 | ALDH1A1 (0.45) | ALDH1A1SLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL16063059 | 0.74 | ALDH1A1 (0.54) | ALDH1A1SLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL22799523 | 0.72 | ALDH1A1 (0.53) | ALDH1A1SLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL22799896 | 0.72 | ALDH1A1 (0.53) | ALDH1A1SLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL14853737 | 0.71 | ALDH1A1 (0.55) | ALDH1A1HPGDLMNABCHEMAPT | |
| SCHEMBL16063071 | 0.71 | ALDH1A1 (0.55) | ALDH1A1HPGDLMNABCHEMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7084125-B2 | Xylo-LNA analogues | EXIQON A/S (DK) | 2006-08-01 | — | — | US | disclosed |
| US-20030082807-A1 | Xylo-LNA analogues | QIAGEN GMBH (DE) | 2003-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082807-A1 | Xylo-LNA analogues | FBL, NSUN2, RNGTT | ALDH1A1 4614/4885SLC6A2 1543/4885SLC6A3 2422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.